EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Progress in immunotherapy for brain metastatic melanoma

Shicheng Zheng, Zhongqiao Lin, Ruibo Zhang, Zihang Cheng, Kaixin Li, Chenkai Gu, Yu Chen, Jing Lin

Frontiers in Oncology · 28.01.2025 · 14

DOI: 10.3389/fonc.2024.1485532 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 28.01.2025. Verfasst von Shicheng Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Fujian Medical University, Fuzhou, Fujian, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is highly aggressive, with brain metastasis being a significant contributor to poor outcomes. Immunotherapy has emerged as a crucial treatment modality for melanoma, particularly for addressing brain metastases. This review explores recent developments in immunotherapy for patients with melanoma brain metastasis, with such treatments encompassing immune checkpoint inhibitors and various immunotherapy combination approaches, such as dual immunotherapy, immunotherapy combined with chemotherapy, immunotherapy combined with targeted drugs, and immunotherapy combined with radiotherapy. This article also discusses existing treatment obstacles and potential future avenues for research and clinical practice.

Schlagwörter

Stichwörter der Autor:innen

brain metastasiscombination therapyimmune checkpoint inhibitorsimmunotherapymelanoma

Autor:innen und Institutionen

  • School of Basic Medicine, Fujian Medical University, Fuzhou, Fujian, China.
  • Phase I Clinical Trial Ward, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
  • Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
  • Cancer Bio-Immunotherapy Center, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.

Zitieren

APA

Zheng, S., Lin, Z., Zhang, R., Cheng, Z., Li, K., Gu, C., Chen, Y., & Lin, J. (2025). Progress in immunotherapy for brain metastatic melanoma. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1485532

Vancouver

Zheng S, Lin Z, Zhang R, Cheng Z, Li K, Gu C, et al. Progress in immunotherapy for brain metastatic melanoma. Frontiers in Oncology. 2025;14. doi:10.3389/fonc.2024.1485532

BibTeX
@article{Zheng2025,
  author = {Zheng, Shicheng and Lin, Zhongqiao and Zhang, Ruibo and Cheng, Zihang and Li, Kaixin and Gu, Chenkai and Chen, Yu and Lin, Jing},
  title = {Progress in immunotherapy for brain metastatic melanoma},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {14},
  doi = {10.3389/fonc.2024.1485532}
}
Kostenlos starten →